Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Andrea Havranová"'
Autor:
Richard Imrich, Ph.D., DSc., Adela Penesová, M.D., Ph.D., Miroslav Vlček, Žofia Rádiková, M.D., Ph.D., Andrea Havranová, M.S., Pavol Šiarnik, M.D., Ph.D., Miroslava Hardoňová, M.D., Branislav Kollár, M.D., Ph.D., Peter Turčáni, M.D., Ph.D.
Publikováno v:
Neurotherapeutics, Vol 21, Iss 4, Pp e00403- (2024)
Externí odkaz:
https://doaj.org/article/601e37dab5a746808a71669378fe21b8
Autor:
Žofia Rádiková, Adela Penesová, Miroslav Vlček, Andrea Havranová, Monika Siváková, Pavel Šiarnik, Ingrid Žitňanová, Richard Imrich, Peter Turčáni, Branislav Kollár
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-10 (2020)
Abstract Background Inflammatory cytokines contribute to proatherogenic changes in lipid metabolism by reduction of HDL-cholesterol (HDL-C) levels, impairment of its antiinflammatory and antioxidant functions. Therefore, the protective actions of HDL
Externí odkaz:
https://doaj.org/article/f5cc8f9a82fc465592c9185954606558
Autor:
Viktor Bielik, Ivan Hric, Simona Ugrayová, Libuša Kubáňová, Matúš Putala, Ľuboš Grznár, Adela Penesová, Andrea Havranová, Sára Šardzíková, Marián Grendar, Eva Baranovičová, Katarína Šoltys, Martin Kolisek
Publikováno v:
Sports medicine - open. 8(1)
Background Physical exercise has favorable effects on the structure of gut microbiota and metabolite production in sedentary subjects. However, little is known whether adjustments in an athletic program impact overall changes of gut microbiome in hig
Publikováno v:
Vnitrni lekarstvi. 64(12)
Proproteinconvertase subtilisin kexin 9 (PCSK9) is a key regulator of low-density lipoprotein receptor (LDLR) expression. Anti-PCSK9 monoclonal antibody (MAb) therapy reduces LDL-cholesterol (LDL-C) by ~60 % and reduces also the risk of major adverse